Founded with a mission to provide rapid, cost-effective manufacturing of pharmaceutical ingredients and complex peptides, AmbioPharm specializes in the development and production of active pharmaceutical ingredients (APIs) and generic peptides. The company supports pharmaceutical and biotech companies by offering services that range from preclinical and clinical development to commercial manufacturing. Their product offerings include GMP and non-GMP services, custom peptide synthesis, vaccine services, and cosmetic peptide manufacturing.
AmbioPharm has garnered attention for its responsive business model and rapid manufacturing processes. Notable affiliated individuals include members of their experienced management team, who bring extensive expertise in pharmaceutical manufacturing. Key achievements include a robust FDA inspection history and successful partnerships with leading biotech firms. The company's impact is evident in its ability to accelerate the development timelines for peptide projects, thereby contributing significantly to advancements in medical research and treatment.
